Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While ...

While previous treatment approaches have ... the researchers have simultaneously discovered a new starting point for therapy: In a mouse model with psoriasis-like skin inflammation, it was shown ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

While previous treatment approaches have mainly focused ... is associated with reduced psoriasis severity, new research ... A Light-Activated Drug to Fight Psoriasis Feb. 3, 2025 — Psoriasis ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

Opens in a new tab or window Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of ...

Up to 1.5 million Britons suffer from the condition and doctors are hailing the new treatment as the most radical advance in psoriasis care for more than 20 years. Existing drugs can take several ...

While previous treatment approaches have mainly focused ... the researchers have simultaneously discovered a new starting point for therapy: In a mouse model with psoriasis-like skin inflammation, it ...